Prof. Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has been appointed honorary professor of the Faculty of Life Sciences at Technische Universität...
Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients....
According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that...
Microorganisms do not just colonize the body of mammals during infections. Billions of microbes can be found on and in healthy humans and animals at any given time, communicating with each other via chemical signals and...
To prepare us for future pandemics, researchers at the Helmholtz Institute for One Health (HIOH) not only look at the pathogens, but also at how changes in the environment and nature - including those caused by us -...
What opportunities lie ahead for the future of medical research and healthcare systems? Researchers from the Helmholtz Association exchange ideas with decision-makers from science, politics, patient organizations,...
The intestinal microbiome is currently the subject of intensive research, as it is of great importance for human health. Intestinal bacteria play an essential role in the defense against dangerous pathogens, which is...
Bacteria are a valuable source for the discovery of natural products that can be used for the development of new drugs. A HIPS research team has now identified two new classes of active substances with antimicrobial...
The Helmholtz Centre for Infection Research (HZI) and the Friends of the HZI are presenting the first event in the Vienna “Sounds and Science” series in cooperation with the Staatstheater Braunschweig. A string quartet...
